This study explored the clinical and economic impact of clinical pharmacological advice (CPA) [based on therapeutic drug monitoring (TDM) results, and on patients' characteristics and co-medications] on personalized linezolid therapy in a tertiary-care hospital.
Titolo: | A 1 year retrospective audit of quality indicators of clinical pharmacological advice for personalized linezolid dosing: one stone for two birds? |
Autori: | |
Data di pubblicazione: | 2016 |
Rivista: | |
Abstract: | This study explored the clinical and economic impact of clinical pharmacological advice (CPA) [based on therapeutic drug monitoring (TDM) results, and on patients' characteristics and co-medications] on personalized linezolid therapy in a tertiary-care hospital. |
Handle: | http://hdl.handle.net/11390/1070839 |
Appare nelle tipologie: | 1.1 Articolo in rivista |
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.